These studies represent promising new treatment options for chronic and progressive kidney diseases, offering renewed hope to ...

Two phase 3 trials will study Kura Oncology’s ziftomenib for frontline acute myeloid leukemia, one with venetoclax and the ...

Covert operations, online takedowns, and multimillion-pound seizures – how regulators are tackling the criminal networks ...

Older adults with apparent hypothyroidism may or may not need treatment. This second article about thyroid disease in older ...

Dr Mark Kris discusses how a small 2015 study with just two nivolumab doses led to a wave of curative-intent trials.

Ethicist Art Caplan discusses FDA layoffs and their impact on protection of human research subjects in clinical trials.

A new opinion paper shows no convincing evidence that there is a causal link between gut bacteria and autism, citing weak ...

Some primary care clinics are investing in social needs programs to overcome barriers to care. New evidence shows how these ...

Medication overuse is a major preventable driver of headache-related disability across the globe, highlighting the need for ...

ACEI and ARB use in CKD has been available for over three decades, but it is still underutilized. Now, a new clinical ...

A systematic review reports that monoclonal antibodies and JAK inhibitors can be effective in the treatment and clearance of ...

A lower maintenance dose of peanut immunotherapy may provide similar effectiveness and an improved safety profile compared ...